Results for tag: "Proliferative Diabetic Retinopathy Drug"

Proliferative Diabetic Retinopathy (PDR) is a complication of diabetes that affects the eyes. It is caused by damage to the blood vessels in the retina, leading to the growth of new, abnormal blood vessels. Endocrine and Metabolic Disorders Drugs are used to treat PDR, including corticosteroids, anti-VEGF agents, and laser photocoagulation. Corticosteroids are used to reduce inflammation and prevent the growth of new blood vessels. Anti-VEGF agents are used to block the growth of new blood vessels and reduce fluid leakage. Laser photocoagulation is used to destroy abnormal blood vessels and reduce the risk of vision loss. Companies in the Proliferative Diabetic Retinopathy Drug market include Novartis, Regeneron Pharmaceuticals, Allergan, Roche, and Bayer. Show Less Read more